National Pharmaceutical Council names Paul VP of clinical, scientific affairs

RESTON, Va. The National Pharmaceutical Council has appointed a new VP for clinical and scientific affairs.

The organization announced Monday that it had appointed Les Paul, who will coordinate NPC’s strategic focus on evidence-based medicine for healthcare decision making, helping to facilitate dialogue between the pharmaceutical industry and stakeholders.

“Dr. Paul’s experience within the pharmaceutical industry, as well as his work in managed care and as practicing physician are real assets for NPC and make him uniquely qualified to lead our new focus on evidence-based medicine,” NPC president Dan Leonard said in a statement.

Paul, who has more than 25 years of experience in health care, previously served as vice president for United States medical affairs at Novartis. He also served for three years as vice president for medical affairs at AstraZeneca.